Dae Sik Kim

Dae Sik Kim

Auto-generated profile, based on publicly available information

Dae Sik Kim

Division of Hematology-Oncology, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Ultrasonography
Verified
Journal Article
Open access
PDF file
DNDong Gyu Na
Dong Gyu Na
DKDae Sik Kim
Dae Sik Kim
SKSoo Jin Kim
Soo Jin Kim
JRJae Wook Ryoo
Jae Wook Ryoo
SJSo Lyung Jung
So Lyung Jung
This study was performed to determine the malignancy risk of thyroid nodules with isolated macrocalcification and to evaluate the diagnostic efficacy of fine-needle aspiration (FNA) and core needle biopsy (CNB). From May 2008 to December 2014, a total of 44 patients with isolated macrocalcifications were enrolled from 4,081 consecutive patients who underwent FNA or CNB at a single institution. We assessed the malignancy risk of nodules with isolated macrocalcification. We compared the diagnostic results between FNA and CNB, and the diagnostic efficacy of each procedure was evaluated by the rate of inconclusive results. We compared the diagnostic performance for malignancy between FNA and CNB with a criterion of malignant or atypia/follicular lesion of undetermined significance (indeterminate) diagnostic results. We investigated whether the ultrasonographic feature of isolated macrocalcification was predictive of malignancy. The malignancy risk of nodules with isolated macrocalcification was 16.1% in 31 nodules with final diagnoses and 11.4% in all nodules. CNB demonstrated a significantly lower rate of nondiagnostic and inconclusive results than FNA (7.7% vs. 53.8%, P=0.002 and 15.4% vs. 57.7%, P=0.003, respectively) in 26 nodules that underwent both FNA and CNB. CNB showed a marginally higher diagnostic performance for identifying malignancy than FNA (P=0.067). The ultrasonographic features of the anterior margin of isolated macrocalcification were not predictive of malignancy (P>0.999). Thyroid nodules with isolated macrocalcification had a low to intermediate malignancy risk and should not be considered benign nodules. CNB showed a higher diagnostic efficacy than FNA in these nodules.

1 April 2016 in Ultrasonography
Verified
Journal Article
Open access
PDF file
DNDong Gyu Na
Dong Gyu Na
JKJi-hoon Kim
Ji-hoon Kim
DKDea Sik Kim
Dea Sik Kim
SKSoo Jin Kim
Soo Jin Kim
The goal of this study was to determine the risk of malignancy of thyroid nodules with minimal cystic changes. A total of consecutive 1,000 thyroid nodules (≥1 cm) with final diagnoses from twoinstitutions were included in this study. The risk of malignancy of thyroid nodules was analyzed according to the internal content, which was categorized as purely solid, minimally cystic (cystic changes ≤10%), and partially cystic (cystic changes >10%). We also assessed the risk of malignancy of nodules with minimal cystic changes depending on echogenicity and presence of any suspicious ultrasonografic (US) features. The overall frequency of purely solid, minimally cystic, and partially cystic noduleswas 730/1,000 (73%), 61/1,000 (6.1%), and 209/1,000 (20.9%), respectively, with risks ofmalignancy of 14.8% (108/730), 3.3% (2/61), and 3.3% (7/209), respectively. The risk ofmalignancy of nodules with minimal cystic changes was significantly lower than that of purelysolid nodules (P=0.013). The risk of malignancy of nodules with minimal cystic changes was also lower than that of purely solid nodules in the group of hypoechoic nodules (P=0.063) and in the group of nodules with suspicious US features (P=0.028), but was not significantly different from that of partially cystic nodules regardless of echogenicity or the presence of suspicious US features (P≥0.652). Thyroid nodules with minimal cystic changes have a low risk of malignancy, similar to that of partially cystic nodules regardless of echogenicity or the presence of suspicious US features. The US lexicon could define solid nodules as nodules with purely solid internal content in order to enhance the accuracy of estimated risks of malignancy.

17 December 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JKJung Sun Kim
Jung Sun Kim
EKEun Joo Kang
Eun Joo Kang
DKDae Sik Kim
Dae Sik Kim
YCYoon Ji Choi
Yoon Ji Choi
SLSuk Young Lee
Suk Young Lee
JKJun Suk Kim
Jun Suk Kim
This study investigated the prognostic effects of venous thromboembolism (VTE)-related factors in patients with metastatic pancreatic cancer receiving palliative chemotherapy. Predictive factors for VTE were also investigated. A total of 216 patients diagnosed with metastatic pancreatic cancer who received gemcitabine-based palliative chemotherapy at our institution were retrospectively evaluated. VTE occurred in 51 (23.6%) patients during treatment and did not affect survival. However, patients who were diagnosed with VTE at the beginning of chemotherapy showed poor prognosis compared with patients diagnosed with VTE during chemotherapy: all patients (hazard ratio [HR] 1.897, p = 0.008); patients diagnosed with VTE (HR = 3.768, p = 0.001). Low serum sodium (Na) (< 135 mmol/L) and high Khorana score (≥3) were strong predictive factors of early VTE (odds ratio [OR] 5.109; 95% confidence interval [95% CI] = 1.010–25.845; p = 0.049 for Khorana score, OR 10.304; 95% CI = 1.036–102.466; p = 0.047) for hyponatremia). Our study demonstrated that occurrence and detection of VTE in the early period of chemotherapy was the most significant VTE-related prognostic factor in patients with metastatic pancreatic cancer receiving chemotherapy. Prediction using the Khorana score and serum Na levels would be helpful in early diagnosis of VTE.

21 April 2023 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
CLCheonghwa Lee
Cheonghwa Lee
HKHa Nui Kim
Ha Nui Kim
JKJung Ah Kwon
Jung Ah Kwon
SYSoo-Young Yoon
Soo-Young Yoon
MJMin Ji Jeon
Min Ji Jeon
JYJung Yoon
Jung Yoon
Cheonghwa Lee, M.D., Ha Nui Kim, M.D., Ph.D., Jung Ah Kwon, M.D., Ph.D., Soo-Young Yoon, M.D., Ph.D., Min Ji Jeon, M.D., Ph.D., Eun Sang Yu, M.D., Dae Sik Kim, M.D., Ph.D., Chul Won Choi, M.D., Ph.D., and Jung Yoon, M.D., Ph.D.. Ann Lab Med 2023;43:503-7. https://doi.org/10.3343/alm.2023.43.5.503

1 July 2020 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
MJMin Ji Jeon
Min Ji Jeon
EYEun Sang Yu
Eun Sang Yu
KKKa-Won Kang
Ka-Won Kang
BLByung-Hyun Lee
Byung-Hyun Lee
YPYong Park
Yong Park
DKDae Sik Kim
Dae Sik Kim
The diagnosis of immune thrombocytopenia (ITP) is based on clinical manifestations and there is no gold standard. Thus, even hematologic malignancy is sometimes misdiagnosed as ITP and adequate treatment is delayed. Therefore, novel diagnostic parameters are needed to distinguish ITP from other causes of thrombocytopenia. Immature platelet fraction (IPF) has been proposed as one of new parameters. In this study, we assessed the usefulness of IPF and developed a diagnostic predictive scoring model for ITP. We retrospectively studied 568 patients with thrombocytopenia. Blood samples were collected and IPF quantified using a fully-automated hematology analyzer. We also estimated other variables that could affect thrombocytopenia by logistic regression analysis. The median IPF was significantly higher in the ITP group than in the non-ITP group (8.7% vs. 5.1%). The optimal cut-off value of IPF for differentiating ITP was 7.0%. We evaluated other laboratory variables via logistic regression analysis. IPF, hemoglobin, lactate dehydrogenase (LDH), and ferritin were statistically significant and comprised a diagnostic predictive scoring model. Our model gave points to each of variables: 1 to high hemoglobin (> 12 g/dL), low ferritin (≤ 177 ng/ mL), normal LDH (≤ upper limit of normal) and IPF ≥ 7 and < 10, 2 to IPF ≥ 10. The final score was obtained by summing the points. We defined that ITP could be predicted in patients with more than 3 points. IPF could be a useful parameter to distinguish ITP from other causes of thrombocytopenia. We developed the predictive scoring model. This model could predict ITP with high probability.

30 April 2022 in Blood Research
Verified
Journal Article
Open access
PDF file
DKDae Sik Kim
Dae Sik Kim
Dae Sik Kim. Blood Res 2022;57:S112-9. https://doi.org/10.5045/br.2022.2022038